Britannia Pharmaceuticals Ltd:企業の戦略的SWOT分析

◆英語タイトル:Britannia Pharmaceuticals Ltd - Strategic SWOT Analysis Review
◆商品コード:SWOT20MY2444
◆発行会社(調査会社):GlobalData
◆発行日:2020年1月
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Britannia Pharmaceuticals Ltd – Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – GlobalData’s summarization of the company’s business strategy.
- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.

Highlights

Britannia Pharmaceuticals Ltd (BPL), a subsidiary of STADA Arzneimittel AG, is a pharmaceutical company, which offers orphan drugs (drugs for rare diseases affecting small patient populations). The company develops and markets products in the area of Parkinson’s disease, wound healing and respiratory disorders. It is also focuses on evaluating opportunities for the neurology market and exploring ways to bring new products into the market. Its products include apomorphine hydrochloride, a dopamine agonist. In addition, the company also developed non-opiate based therapeutics for the treatment of opiate detoxification and withdrawal. BPL is headquartered in Berkshire, the UK.

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
Section 1 – About the Company
Britannia Pharmaceuticals Ltd – Key Facts
Britannia Pharmaceuticals Ltd – Key Employees
Britannia Pharmaceuticals Ltd – Major Products and Services
Britannia Pharmaceuticals Ltd – History
Britannia Pharmaceuticals Ltd – Locations And Subsidiaries
Head Office
Section 2 – Company Analysis
Company Overview
Britannia Pharmaceuticals Ltd – Business Description
Britannia Pharmaceuticals Ltd – SWOT Analysis
SWOT Analysis – Overview
Britannia Pharmaceuticals Ltd – Strengths
Britannia Pharmaceuticals Ltd – Weaknesses
Britannia Pharmaceuticals Ltd – Opportunities
Britannia Pharmaceuticals Ltd – Threats
Britannia Pharmaceuticals Ltd – Key Competitors
Section 3 – Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

List of Tables
Britannia Pharmaceuticals Ltd, Key Facts
Britannia Pharmaceuticals Ltd, Key Employees
Britannia Pharmaceuticals Ltd, Major Products and Services
Britannia Pharmaceuticals Ltd, History
Britannia Pharmaceuticals Ltd, Key Competitors

★海外企業調査レポート[Britannia Pharmaceuticals Ltd:企業の戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Sigmatech, Inc.:企業の戦略・SWOT・財務情報
    Sigmatech, Inc. - Strategy, SWOT and Corporate Finance Report Summary Sigmatech, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • New Standard Energy Ltd (NSE):石油・ガス:M&Aディール及び事業提携情報
    Summary New Standard Energy Ltd (NSE), formerly Hawk Resources Ltd, is an oil and gas exploration and production company. The company carries out acquisition, exploration, and develops oil and gas; and hydrocarbon properties. It holds interest in production and development project in the Eagle Ford …
  • Hyposwiss Private Bank Geneve SA:企業の戦略・SWOT・財務情報
    Hyposwiss Private Bank Geneve SA - Strategy, SWOT and Corporate Finance Report Summary Hyposwiss Private Bank Geneve SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Affimed GmbH (AFMD):企業の財務・戦略的SWOT分析
    Summary Affimed GmbH (Affimed), formerly Affimed Therapeutics AG, a subsidiary of Affimed NV, discovers and develops immunotherapies to treat hematologic cancers and solid tumors. The company is investigating AFM13, an innate cell engager, for the treatment of Peripheral T cell lymphoma, transformed …
  • Trimble Solutions Oy:企業の戦略的SWOT分析
    Trimble Solutions Oy - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Strides Shasun Limited:企業のM&A・事業提携・投資動向
    Strides Shasun Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Strides Shasun Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions …
  • Auris Medical Holding AG (EARS):企業の財務・戦略的SWOT分析
    Auris Medical Holding AG (EARS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Cosmo Energy Holdings Co Ltd (5021):企業の財務・戦略的SWOT分析
    Cosmo Energy Holdings Co Ltd (5021) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Westar Energy Inc.:企業の戦略・SWOT・財務情報
    Westar Energy Inc. - Strategy, SWOT and Corporate Finance Report Summary Westar Energy Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Peel Hotels Plc:企業の戦略・SWOT・財務情報
    Peel Hotels Plc - Strategy, SWOT and Corporate Finance Report Summary Peel Hotels Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Samsung Heavy Industries Co., Ltd.:企業の戦略・SWOT・財務分析
    Samsung Heavy Industries Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Samsung Heavy Industries Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Clinical Innovations LLC:医療機器:M&Aディール及び事業提携情報
    Summary Clinical Innovations LLC (Clinical Innovations), a portfolio company of EQT AB, is a medical device company that researches and manufactures healthcare products to improve the lives of mothers and their babies. The company focuses on labor, delivery and neonatal intensive care. Its major pro …
  • Nuformix Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Nuformix Ltd (Nuformix) is a provider of pharmaceutical cocrystallisation products. The company develops and manufactures products in reprofiling, supergenerics and emerging markets areas. It offers methodologies for rational solid form discovery; and provides technologies for rapid solid fo …
  • Allison Transmission Holdings Inc:企業の戦略・SWOT・財務情報
    Allison Transmission Holdings Inc - Strategy, SWOT and Corporate Finance Report Summary Allison Transmission Holdings Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Mazda Motor Corporation:企業の戦略・SWOT・財務情報
    Mazda Motor Corporation - Strategy, SWOT and Corporate Finance Report Summary Mazda Motor Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • G1 Therapeutics Inc (GTHX)-製薬・医療分野:企業M&A・提携分析
    Summary G1 Therapeutics Inc (G1 Therapeutics), formerly G Zero Therapeutics Inc is a healthcare company that develops novel, and small molecule therapies. The company pipeline products include CDK4/6, trilaciclib G1T28 a drug candidate; G1T38 a potential best compound, and G1T48. It undertakes disco …
  • LOT Polish Airlines SA:企業の戦略・SWOT・財務分析
    LOT Polish Airlines SA - Strategy, SWOT and Corporate Finance Report Summary LOT Polish Airlines SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • True Corporation Public Company Limited:企業の戦略・SWOT・財務情報
    True Corporation Public Company Limited - Strategy, SWOT and Corporate Finance Report Summary True Corporation Public Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT a …
  • Abbott Vascular Inc:医療機器:M&Aディール及び事業提携情報
    Summary Abbott Vascular Inc (Abbott Vascular), formerly Perclose, Inc., a subsidiary of Abbott Laboratories, is a medical device company that develops manufactures and markets cardiovascular devices. The company offers coronary intervention, peripheral intervention, and structural heart products. It …
  • Evoqua Water Technologies Corp (AQUA):企業の財務・戦略的SWOT分析
    Evoqua Water Technologies Corp (AQUA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆